EUVIMEDEUVIMED entdecken
Crossref

N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions

Pyeong Hwa Kim, Chong Hyun Suh, Eun Bee Jang, Seonok Kim, Kye Jin Park, Hyo Jung Park, Ah Young Kim, Kyung-Hyun Do, Jeong Hyun Lee, Jin Hyoung Kim, Ah Young Jung, Choong Wook Lee

European Radiology · 16.04.2024 · 34 (10) · 6444-6453

DOI: 10.1007/s00330-024-10730-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, online erschienen am 16.04.2024. Verfasst von Pyeong Hwa Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Contrast Media, Recurrence, Tomography, X-Ray Computed. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Guerbet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To determine whether switching to contrast media based on the sharing of N-(2,3-dihydroxypropyl) carbamoyl side chain reduces the recurrence of iodinated contrast media (ICM)-associated adverse drug reactions (ADRs). MATERIALS AND METHODS: This single-center retrospective study included 2133 consecutive patients (mean age ± SD, 56.1 ± 11.4 years; male, 1052 [49.3%]) who had a history of ICM-associated ADRs and underwent contrast-enhanced CT examinations. The per-patient and per-exam-based recurrence ADR rates were compared between cases of switching and non-switching the ICM from ICMs that caused the previous ADRs, and between cases that used ICMs with common and different carbamoyl side chains from ICMs that caused the previous ADRs. Downgrade rates (no recurrence or the occurrence of ADR less severe than index ADRs) were also compared. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) analysis were additionally performed. RESULTS: In per-patient analysis, switching of ICM showed a lower recurrence rate (switching, 10.4% [100/965] vs. non-switching, 28.4% [332/1168]), with the adjusted odds ratio (OR) of 0.27 (95% CI: 0.21, 0.34; p < 0.001). The result was consistent in PSM (OR, 0.29 [95% CI: 0.22, 0.39]; p < 0.001), IPTW (OR, 0.28 [95% CI: 0.22, 0.36]; p < 0.001), and in per-exam analysis (5.5% vs. 13.8%; OR, 0.32 [95% CI: 0.27, 0.37]; p < 0.001). There was lower per-exam recurrence (5.0% [195/3938] vs. 7.8% [79/1017]; OR, 0.63 [95% CI: 0.47, 0.83]; p = 0.001) and higher downgrade rates (95.6% [3764/3938] vs. 93.3% [949/1017]; OR, 1.51 [95% CI: 1.12, 2.03]; p = 0.006) when using different side chain groups. CONCLUSION: Switching to an ICM with a different carbamoyl side chain reduced the recurrent ADRs and their severity during subsequent examinations. CLINICAL RELEVANCE STATEMENT: Switching to an iodinated contrast media with a different carbamoyl side chain reduced the recurrent adverse drug reactions and their severity during subsequent examinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaRecurrenceTomography, X-Ray ComputedHumansMaleFemaleMiddle AgedRetrospective StudiesDrug-Related Side Effects and Adverse ReactionsAgedRisk FactorsIodine

Stichwörter der Autor:innen

Contrast mediaDrug-related side effects and adverse reactionsTomography, X-ray computed

Substanzen

Contrast MediaIodine

Autor:innen und Institutionen

  • Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. cwlee@amc.seoul.kr.

Förderung

  • Guerbet

Zitieren

APA

Kim, P. H., Suh, C. H., Jang, E. B., Kim, S., Park, K. J., Park, H. J., Kim, A. Y., Do, K. H., Lee, J. H., Kim, J. H., Jung, A. Y., & Lee, C. W. (2024). N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions. European Radiology, 34(10), 6444-6453. https://doi.org/10.1007/s00330-024-10730-7

Vancouver

Kim PH, Suh CH, Jang EB, Kim S, Park KJ, Park HJ, et al. N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions. European Radiology. 2024;34(10):6444-6453. doi:10.1007/s00330-024-10730-7

BibTeX
@article{Kim2024,
  author = {Kim, Pyeong Hwa and Suh, Chong Hyun and Jang, Eun Bee and Kim, Seonok and Park, Kye Jin and Park, Hyo Jung and Kim, Ah Young and Do, Kyung-Hyun and Lee, Jeong Hyun and Kim, Jin Hyoung and Jung, Ah Young and Lee, Choong Wook},
  title = {N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions},
  journal = {European Radiology},
  year = {2024},
  volume = {34},
  number = {10},
  pages = {6444--6453},
  doi = {10.1007/s00330-024-10730-7}
}
Kostenlos starten →